News
AZoNano on MSN46m
Targeted Nanozyme Therapy for HER2 CancerA new nanozyme-antibody platform selectively targets HER2-positive tumors, disrupting gene expression and reducing metastasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback